Activity Report March 2013 February 2014
|
|
- Sheryl Rice
- 5 years ago
- Views:
Transcription
1 West of Scotland Cancer Network Skin Cancer Managed Clinical Network Activity Report March 2013 February 2014 Dr Girish Gupta Consultant Dermatologist MCN Clinical Lead Tom Kane MCN Manager West of Scotland Cancer Network
2 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION 5 2. MCN WORKPLAN AND ACTIVITIES (REPORTING PERIOD 03/2013 TO 02/2014) CORE OBJECTIVES INDIVIDUAL MCN OBJECTIVES OTHER MCN ACTIVITIES 6 3. QUALITY ASSURANCE / SERVICE DEVELOPMENT AND IMPROVEMENT 7 4. KEY PRIORITY AREAS FOR THE MCN IN THE NEXT 12 MONTHS 9 5. CONCLUSION 9 ACKNOWLEDGEMENT 10 West of Scotland Cancer Network 2
3 Executive Summary Introduction The purpose of this document is to report the Skin Cancer Managed Clinical Network (MCN) activities in respect of: Performance against agreed objectives; Outcomes achieved; and Challenges encountered and actions taken to remedy defined issues. This activity report covers March 2013 to February It also reports on key audit findings and resultant actions from the 2012 clinical audit, as well as looking forward from March 2014 to February MCN Objectives The Skin Cancer MCN has made progress and delivered a number of key objectives. Guideline and Protocol Development Development and updating of Clinical Management Guidelines (CMGs) remains a core component of MCN activity. The Squamous Cell Carcinoma (SCC) CMG has been reviewed and updated. The Malignant Melanoma (MM) CMG is nearing completion. Service Mapping A high level map of skin service provision has been collated for all NHS Boards across the region, detailing the points of service delivery and the connections between them. Multi-disciplinary Team (MDT) Working Following the publication of the Lymphoma Quality Performance Indicators (QPIs) the MCN has been working collaboratively with colleagues from the Haemato-oncology MCN to promote implementation of QPI 10 which states that patients with primary cutaneous lymphoma should be discussed at a specialist MDT meeting. Implementation of Regional Follow Up Consensus Guidelines The Follow Up Regional Consensus Guidelines for the three skin cancers was issued to the NHS Boards in October 2011 and is scheduled for review in October Advisory Board members from across all Boards have confirmed that they are broadly adhering to the guidelines. Quality Performance Indicator Development Quality Performance Indicators (QPIs) for MM are in the development phase with a short list of QPIs agreed by the national group, which has representation by MCN members. Draft indicators are currently being refined ahead of dataset development and engagement. Wide clinical and public engagement commenced in January 2014, with the QPIs expected to be published in summer Regional Clinical Audit The 2012 clinical audit data report was published in September 2013 and is available on the West of Scotland Cancer Network (WoSCAN) website. Action plans are being monitored through the Advisory Board. West of Scotland Cancer Network 3
4 Key Priority Areas for the MCN in the next 12 months The MCN work plan has been developed with an emphasis on identifying outcomes that improve the quality of patient care and overall efficiency. A number of objectives will be carried over from this year as guideline and protocol development, service mapping, QPI development and clinical audit continue as priorities in the work plan. New MCN objectives to be progressed in the coming year are listed below: Reviewing the follow up of organ transplant patients who are at a higher risk of skin cancers to ensure equity of care for patients who are followed up in their local NHS Boards Initiate the planning required to undertake the periodic review of the regional consensus guidelines for the follow up of all skin cancers. West of Scotland Cancer Network 4
5 1. Introduction The Skin Cancer Managed Clinical Network (MCN) was established in 2004 as a means of delivering equitable high quality clinical care to all skin cancer patients across four NHS Boards; Ayrshire & Arran, Forth Valley, Greater Glasgow and Clyde and Lanarkshire covering a population of approximately 2.46 million. The Skin Cancer MCN continues to support and develop the clinical service for skin cancer patients with the three skin cancers (Malignant Melanoma MM, Squamous Cell Carcinoma SCC and Basal Cell Carcinoma BCC). The 2012 West of Scotland Cancer Network (WoSCAN) audit data indicates that the number of MM in that year was 537. The effective management of these patients throughout the region relies on co-ordinated delivery of treatment and care that requires close collaboration of professions from a range of specialties. Predominantly, it is the MM patients who are discussed in the six local and one regional skin multi-disciplinary team meetings (MDTs) across the West of Scotland (WoS) but where there are concerns with any particular non melanoma skin cancer patients, they will also be taken to the MDTs for discussion. The purpose of this document is to report the Skin MCN activities in respect of: Performance against agreed objectives; Outcomes achieved; Challenges encountered and actions taken to remedy defined issues; and Update on progress of actions identified from the Audit Report. MCN Governance The Advisory Board meets three times per annum with representation from each of the partner NHS Boards and all relevant specialities involved in the management of skin cancers. The Advisory Board is consulted between meetings as required by the lead and manager. Dr Girish Gupta has now stepped down from his role as Clinical Lead following five productive years in office. The position of Skin Cancer MCN Clinical Lead has gone out to advert and an appointment will be made in early The terms of reference and membership of the Advisory Board will be refreshed to reflect these changes. 2. MCN Workplan and Activities (reporting period 03/2013 to 02/2014) 2.1 Core Objectives Regional Clinical Audit Programme A key area of the Skin Cancer MCN was to effectively utilise audit findings to inform and drive service improvement. A comprehensive clinical audit report of performance against key outcome measures (KOMs) was issued to NHS Boards in September 2013 and is available on the WoSCAN website. Progress against action plans is being discussed on a regular basis at the Advisory Board. The Skin Cancer MCN is encouraged by the performance of individual units against the regionally agreed KOMs with results demonstrating that patients with MM receive a consistent and improving standard of care across all geographical locations. West of Scotland Cancer Network 5
6 Service Mapping A high level map of skin service provision has been collated for all NHS Boards across the region, detailing the points of service delivery and the connections between them. The mapped information was included in a regional report presented to the Regional Cancer Clinical Leads Group in early October 2013 and subsequently shared with Cancer Managers. The map will be updated annually to maintain a baseline position. 2.2 Individual MCN Objectives Review of Clinical Management Guidelines (CMGs) CMGs ensure the safe and equitable management of patients across the West of Scotland Cancer Network area whilst optimising the effectiveness of treatment and care. The MCN has completed the review of the SCC CMG and is continuing to work on the MM CMG to include a new drug approved by the Scottish Medicines Consortium in December Multi-disciplinary Team (MDT) Working Following the publication of the Lymphoma Quality Performance Indicators (QPIs) the MCN has been working collaboratively with colleagues from the Haemato-oncology MCN to promote implementation of QPI 10 which states that patients with primary cutaneous lymphoma should be discussed at a specialist MDT meeting. A referral template has been circulated to dermatologists by the MCN and a reminder is circulated monthly by the MDT co-ordinator. Implementation of Regional Follow Up Consensus Guidelines The Follow Up Regional Consensus Guidelines for the three skin cancers was issued to the NHS Boards in October 2011 and is scheduled for review in October Advisory Board members from across all Boards have confirmed that they are broadly adhering to the guidelines. Quality Performance Indicator Development QPIs for MM have been developed by a national group, which had representation by MCN members. Wide clinical and public engagement commenced in January 2014, with the QPIs expected to be published in summer Other MCN Activities National Institute for Health and Clinical Excellence (NICE NHS England) The Advisory Board reviewed the NICE guidance for the use of Electro-chemotherapy in the treatment of Primary Basal Cell Carcinoma and Primary Squamous Cell Carcinoma within the WoSCAN context. The Advisory Board noted that what evidence there is to support it is poor and agreed that there was not a value in proceeding with it at this time. Merkel Cell Carcinoma (MCC) The MCN is currently supporting colleagues throughout Scotland to complete a Scotland wide audit of MCC presentation and management over the last decade. This audit is scheduled to complete in March MCC is a rare and aggressive neuro-endocrine skin cancer. Patients with MCC have a median survival of 31 months and this disease carries a greater overall risk of mortality than malignant melanoma. The management of MCC has been noted to be variable across the United Kingdom and this observational study will examine how MCC cases have been managed in Scotland during and attempt to identify any major prognostic indicators in this cohort. West of Scotland Cancer Network 6
7 Scottish Intercollegiate Guidelines Network (SIGN) MCN members are currently working with SIGN to develop guidelines for the management of primary cutaneous SCC. Once the national guidelines are available, the MCN will review the WoSCAN CMG and Follow Up Regional Consensus Guidelines in the light of recommended changes to clinical practice. 3. Quality Assurance / Service Development and Improvement The primary function of the MCN is to facilitate continuous clinical service improvement, supporting delivery of high-quality, equitable, treatment and care to patients with skin cancers in the WoS. The MCN prospective clinical audit programme underpins much of the regional service development and improvement work of the MCN and supports quality assurance (QA) by providing the means for regular assessment and reporting against recognised and agreed measures of service performance and quality. The annual regional quality assurance of service provision utilises six regionally agreed KOMs in addition to basic demographics. The latest report of audit data is based on 537 new cases of MM presenting in 2012, set against results obtained from the previous report. The MCN QA process requires local multi-disciplinary teams to critically review and verify their own results before being collated to provide a regional comparative report of performance against agreed measures and variance between MDTs. The report of the 2012 clinical audit data was published in September 2013 and can be found in the WoSCAN internet site. Regional Audit and Governance Process In accordance with agreed governance procedures, Boards were asked to produce Action/Improvement Plans in response to audit findings and to take forward recommendations set out in the Audit Report. The expectation is that these actions will be progressed and monitored via local governance structures. Plans are expected to be submitted to the Regional Information Manager within two months of publication of the report. An Action/Improvement Plan template is provided to ensure consistency and standardisation across the region. The MCN Manager/Clinical Lead have been reviewing Board Action Plans to identify priorities for co-ordinated regional action and these, along with progress against specific Board actions are monitored throughout the year by the Advisory Board under the standing MCN Work Plan agenda item. Action Plan Progression Recommended actions on the basis of the key findings of the audit report were directed to Boards requesting the development of local plans to address areas of deficiency identified. Skin Cancer Action/Improvement plans have been submitted by each of the NHS Boards. Outlined below is a high level summary of progress on actions required. Service Improvement Ayrshire & Arran is encouraging the use of photo-triage to speed up referrals of suspicions lesions. Forth Valley is continuing to work to improve the knowledge base of primary care clinicians in respect of skin cancers. Greater Glasgow and Clyde and Lanarkshire have written or plan to write to colleagues in primary care to highlight the importance of referring appropriate patients urgently. Ayrshire & Arran and also Greater Glasgow and Clyde have reviewed cases where excisions have been performed in primary care. Ayrshire & Arran indicated that the biopsies were carried out by General Practitioners with a special interest (GPwSI) in skin cancers. They will West of Scotland Cancer Network 7
8 ensure that the data for GPwSI is entered correctly. Greater Glasgow and Clyde advise that the numbers are small and that they are now requesting feedback from GPs after each specific case. Ayrshire & Arran has reviewed the cases where biopsy was performed prior to surgical treatment, noting that there were four cases and that all were considered clinically appropriate. All NHS Boards have reviewed clinical practice to ensure that further increases in biopsy prior to surgical resection are not observed. Reasons for each of the biopsies that were performed have been noted. Forth Valley has reviewed their surgical techniques in respect of compliance with the SIGN guideline recommendation. Forth Valley noted that three patients failed to meet the standard. Patients will be discussed at the multi-disciplinary team meeting to prevent this occurring. All NHS Boards have reviewed the number of patients undergoing wide local excision to determine if the relatively low numbers are due to a data recording issue or demonstrate a change in clinical practice. Ayrshire & Arran is in the process of identifying a robust process to collect this information for patients treated in Glasgow. Greater Glasgow and Clyde plan to review the 2013 data following Electronic Patient Records (EPR) implementation. Forth Valley noted that the majority of these patients progress to wider excision, which was not being recorded; Forth Valley will change practice accordingly. Lanarkshire noted that the numbers of patients not having a wide local excision was low and itemised the reasons for each patient not having the procedure. Data Quality Improvement Ayrshire & Arran has reviewed case ascertainment. All melanoma related pathology is now sent directly to the lead audit data facilitator and this process has been confirmed by pathology. Ayrshire & Arran is now also crosschecking the list of audit patients with MDT minutes and tracking database to increase case ascertainment. Lanarkshire has reviewed audit data collection processes to ensure complete and accurate data capture for surgical excision margins. Access to the Glasgow Clinical Portal has been granted to all cancer audit staff in Lanarkshire, meaning that operation notes can now be viewed in Lanarkshire which will ensure complete and accurate data capture for surgical margins. Greater Glasgow and Clyde and NHS Lanarkshire have reviewed audit data collection processes. Greater Glasgow and Clyde advise that EPR implementation has significantly improved data capture. Across all Boards all the actions identified in the Board-specific action/improvement plans have been reviewed and a progress/action status provided in line with the governance framework; for those actions that remain ongoing a further update will be requested at the next Advisory Board meeting. The expectation is that all actions would be addressed prior to the onset of the next audit reporting schedule with sign off of the 2013 clinical audit data completed in August Escalation Process Any service or clinical issue which the Advisory Board considers not to have been adequately addressed will be escalated to the Regional Lead Cancer Clinician and relevant Territorial NHS Board Cancer Clinical Lead by the MCN Clinical Lead. West of Scotland Cancer Network 8
9 4. Key Priority Areas for the MCN in the next 12 months The MCN work plan is currently being finalised with an emphasis on identifying outcomes that improve the quality of patient care and overall efficiency. The work plan is expected to be published by early May Below are the objectives to be progressed in the coming year: Core Objectives: Continue to support the regional clinical audit programme and effectively utilise audit findings to inform and drive service improvement. Support delivery of the national cancer QPI development programme. Update the regional service map for skin cancer service provision. Individual MCN Objectives: In addition to guideline development, the Network will also review the follow up of organ transplant patients who are at an increased risk of skin cancers and initiate the planning required to undertake the 3-yearly periodic review of the regional consensus guidelines for the follow up of all skin cancers; this will require engagement with all disciplines involved in the follow up care of patients. 5. Conclusion This has been a productive year and the MCN, with the support of the Advisory Board, has continued to work closely with local and regional clinical and management teams across the WoS to progress the work plan objectives. Ongoing development and update of CMGs and other regional guidance continue to drive consistency of practice and provide improved care for patients with skin cancers in the WoS. Recognising the pressures on clinical time, the MCN is looking at the most time efficient and effective way to engage and involve members in MCN activities to ensure essential clinical input to the ongoing improvement and development of skin cancer services in the WoS. Looking ahead the membership welcomes the opportunity to improve quality of clinical audit data, assess the probable implications of the QPI process and continue to support and improve the treatment pathway and effective patient journey around local and regional services. West of Scotland Cancer Network 9
10 Acknowledgement This report represents the achievements and challenges progressed across the NHS Boards of the West of Scotland Cancer Network: NHS Ayrshire & Arran NHS Forth Valley NHS Greater Glasgow and Clyde NHS Lanarkshire We would like to thank all members and active participants in the cancer network for their continued support of the Managed Clinical Network, without their efforts this level of progress would not be possible. West of Scotland Cancer Network 10
Activity Report March 2012 February 2013
Lung Cancer Managed Clinical Network Activity Report March 2012 February 2013 John McPhelim Lead Lung Cancer Nurse MCN Clinical Lead Kevin Campbell Network Manager CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationActivity Report July 2012 June 2013
Urological Cancers Managed Clinical Network Activity Report July 2012 June 2013 Mr Seamus Teahan Consultant Urologist MCN Clinical Lead Tom Kane MCN Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationActivity Report July 2014 June 2015
West of Scotland Cancer Network Gynaecological Cancer Managed Clinical Network Activity Report July 2014 June 2015 Nadeem Siddiqui Consultant Gynaecological Oncologist MCN Clinical Lead Kevin Campbell
More informationActivity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2013 March 2014 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationActivity Report April 2012 March 2013
Colorectal Cancer Managed Clinical Network Activity Report April 2012 March 2013 Paul Horgan Professor of Surgery MCN Clinical Lead Kevin Campbell Network Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationActivity Report April 2012 March 2013
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2012 March 2013 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationActivity Report April 2012 March 2013
Gynaecological Cancer Managed Clinical Network Activity Report April 2012 March 2013 Nadeem Siddiqui MCN Clinical Lead Kevin Campbell Network Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION 4 2.
More informationActivity Report April 2012 to March 2013
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2012 to March 2013 Professor Roy Rampling Emeritus Professor
More informationActivity Report July 2014 June 2015
Urological Cancers Managed Clinical Network Activity Report July 2014 June 2015 Mr Gren Oades Consultant Urologist MCN Clinical Lead Tom Kane MCN Manager CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION 5
More informationActivity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks Sarcoma National Managed Clinical Network Activity Report April 2013 March 2014 Dr Jeff White Consultant Oncologist NMCN Clinical Lead Lindsay Campbell
More informationActivity Report April 2014 March 2015
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2014 March 2015 Dr Avinash Kanodia Consultant Radiologist
More informationActivity Report April June 2012
Urological Cancers Managed Clinical Network Activity Report April 2011- June 2012 Mr Seamus Teahan Consultant Urologist MCN Clinical Lead Tom Kane MCN Manager CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationHead and Neck Cancer MCN Work Plan 2017/18
Head and Neck Cancer MCN Work Plan /18 Objective Deliverables / Outcomes Lead 1. Manage the development/review of Head and Neck Cancer Management Guidelines and Clinical Guidance Documents. 1.1 Identify
More informationAnnual Report April 2016 March 2017
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Annual Report April 2016 March 2017 Professor Stephen Wigmore Consultant Surgeon
More informationLung Cancer MCN Work Plan 2017/18
Lung Cancer MCN Work Plan /18 Objective Deliverables / Outcomes Lead 1. Manage the development/review of Lung Cancer Management Guidelines Regional Management Guidelines circulated for implementation.
More informationAudit Report Report of the 2011 Clinical Audit Data
Lung Cancer Managed Clinical Network Audit Report Report of the 2011 Clinical Audit Data Dr Richard Jones Consultant Clinical Oncologist MCN Clinical Lead Kevin Campbell MCN Manager Julie McMahon Information
More informationScottish Cancer Taskforce: National Cancer Quality Steering Group Cancer Clinical Audit
Scottish Cancer Taskforce: National Cancer Quality Steering Group Cancer Clinical Audit National Cancer Clinical Audit: Baseline Survey Report (May 09) Purpose: The purpose of this paper is to provide
More informationAudit Report. Testicular Cancer Quality Performance Indicators. West of Scotland Cancer Network. Urological Cancer Managed Clinical Network
Urological Cancer Managed Clinical Network Audit Report Testicular Cancer Quality Performance Indicators Clinical Audit Data: 01 October 2014 to 30 September 2015 Mr Gren Oades MCN Clinical Lead Tom Kane
More informationAudit Report Acute Leukaemia Quality Performance Indicators
Haemato-oncology Managed Clinical Network Audit Report Acute Leukaemia Quality Performance Indicators Clinical Audit Data: 01 July 2014 to 30 June 2017 Dr Mark Drummond Consultant Haematologist MCN Clinical
More informationUpper GI Cancer Quality Performance Indicators
Publication Report Upper GI Cancer Quality Performance Indicators Patients diagnosed during January 2013 to December 2015 Publication date 28 th March 2017 An Official Statistics Publication for Scotland
More informationNATIONAL MANAGED CLINICAL NETWORK FOR ADULT NEURO-ONCOLOGY ANNUAL REPORT 2010/11
NATIONAL MANAGED CLINICAL NETWORK FOR ADULT NEURO-ONCOLOGY ANNUAL REPORT 2/11 Hosted by West of Scotland Cancer Network (WoSCAN) North, South East and West of Scotland Cancer Networks Contents Contents...ii
More informationOvarian Cancer Quality Performance Indicators
Ovarian Cancer Quality Performance Indicators Patients diagnosed between October 2013 and September 2016 Publication date 20 February 2018 An Official Statistics publication for Scotland This is an Official
More informationSquamous Cell Carcinoma. Basal Cell Carcinoma. Regional Follow-up Guidelines
West of Scotland Cancer Network Skin Cancer Managed Clinical Network Squamous Cell Carcinoma Basal Cell Carcinoma Regional Follow-up Guidelines Prepared by Dr M Porter, Dr A Matthews Approved by Skin Cancer
More informationAudit Report Lymphoma Quality Performance Indicators
West of Scotland Cancer Network Haemato-oncology Managed Clinical Network Audit Report Lymphoma Quality Performance Indicators Clinical Audit Data: 01 October 2016 to 30 September 2017 Dr Grant McQuaker
More informationCANCER IN SCOTLAND: ACTION FOR CHANGE The structure, functions and working relationships of Regional Cancer Advisory Groups
CANCER IN SCOTLAND: ACTION FOR CHANGE The structure, functions and working relationships of Regional Cancer Advisory Groups Introduction/Background 1. Our National Health: A Plan for action, a plan for
More informationClinical Audit Data: 01 October 2015 to 30 September West of Scotland Cancer Network. Gynaecological Cancer Managed Clinical Network
Gynaecological Cancer Managed Clinical Network Audit Report Ovarian Cancer Quality Performance Indicators Cervical Cancer Quality Performance Indicators Endometrial Cancer Quality Performance Indicators
More informationAudit Report. Testicular Cancer Quality Performance Indicators. West of Scotland Cancer Network. Urological Cancer Managed Clinical Network
West of Scotland Cancer Network Urological Cancer Managed Clinical Network Audit Report Testicular Cancer Quality Performance Indicators Clinical Audit Data: 01 October 2015 to 30 September 2016 Mr Gren
More informationAudit Report Report of the 2012 Clinical Audit Data
Urological Cancer Managed Clinical Network Audit Report Report of the 2012 Clinical Audit Data Mr Seamus Teahan MCN Clinical Lead Tom Kane MCN Manager Sandie Ker Information Officer Urological Cancer Audit
More informationAudit Report Report of the 2010 Clinical Audit Data
Gynaecological Cancer Managed Clinical Network Audit Report Report of the Clinical Audit Data Nick Reed Consultant Clinical Oncologist MCN Clinical Lead (Joint) Nadeem Siddiqui Consultant Gynaecological
More informationAudit Report Report of the 2012 Clinical Audit Data
Gynaecological Cancer Managed Clinical Network Audit Report Report of the 2012 Clinical Audit Data Nadeem Siddiqui Consultant Gynaecological Oncologist MCN Clinical Lead Kevin Campbell MCN Manager Julie
More informationAudit Report. Upper GI Cancer Quality Performance Indicators. Report of the 2016 Clinical Audit Data. West of Scotland Cancer Network
Upper Gastro-intestinal Cancer Managed Clinical Network Audit Report Upper GI Cancer Quality Performance Indicators Report of the 216 Clinical Audit Data Mr Matthew Forshaw MCN Clinical Lead Tracey Cole
More informationAudit Report Endometrial & Cervical Cancer Quality Performance Indicators
Gynaecological Cancer Managed Clinical Network Audit Report Endometrial & Cervical Cancer Quality Performance Indicators Clinical Audit Data: 01 October 2014 to 30 September 2015 Nadeem Siddiqui Consultant
More informationAudit Report. Bladder Cancer Quality Performance Indicators. West of Scotland Cancer Network. Urological Cancer Managed Clinical Network
Urological Cancer Managed Clinical Network Audit Report Bladder Cancer Quality Performance Indicators Clinical Audit Data: 01 April 2015 to 31 March 2016 Mr Gren Oades MCN Clinical Lead Tom Kane MCN Manager
More informationWest of Scotland Cancer Network. Transforming Care After Treatment (TCAT) Implementation Steering Group. Terms of Reference
West of Scotland Cancer Network Transforming Care After Treatment (TCAT) Implementation Steering Group Terms of Reference CONTENTS 1. Purpose 3 2. Background 3 3. Objectives 3 4. Scope 3 5. Constraints
More informationRegional Follow-up Guidelines
Breast Cancer Managed Clinical Network Breast Cancer Regional Follow-up Guidelines Prepared by J McIlhenny/ I Reid Approved by Breast Cancer MCN Advisory Board/ RCCLG Issue date July 2017 Review date July
More informationAudit Report. Report of the 2014 Clinical Audit Data. North, South East and West of Scotland Cancer Networks
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Audit Report Report of the 2014 Clinical Audit Data Professor Stephen Wigmore Consultant
More informationConsultation on publication of new cancer waiting times statistics Summary Feedback Report
Consultation on publication of new cancer waiting times statistics Summary Feedback Report Information Services Division (ISD) NHS National Services Scotland March 2010 An electronic version of this document
More informationongoing development of governance and leadership to support improvement ongoing national roll out of the electronic palliative care summary (epcs)
Update to the Review of Palliative Care Services in Scotland Since the publication of Living and Dying Well a national action plan for palliative and end of life care in Scotland in October 2008 considerable
More informationAudit Report Report of the 2011 Clinical Audit Data
Breast Cancer Managed Clinical Network Audit Report Report of the 2011 Clinical Audit Data Dr Ruth Adamson Consultant Pathologist MCN Clinical Lead Tom Kane MCN Manager Julie McMahon Information Officer
More informationDear Colleague. DL (2017) June Additional Funding for CGMs and Adult Insulin Pumps Summary
The Scottish Government Healthcare Quality & Improvement Directorate DG Health & Social Care Dear Colleague Additional Funding for CGMs and Adult Insulin Pumps 2017-18 Summary On 7 December 2016, the First
More informationProject Brief. New Cancer Waiting Times. Data Quality Assurance Audit
Project Brief New Cancer Waiting Times Data Quality Assurance Audit Version 1.0 Contents 1 Introduction...3 2 Data Recording and Submitting...4 3 Data Quality Assurance Audit...4 3.1 Areas of Investigation:...4
More informationReport prepared on behalf of the Scottish Head and Neck Cancer Networks by the WoSCAN Information Team
Scottish Head and Neck Cancer Networks Report of the 2011 Clinical Audit Data Presented at the National Head and Neck Cancer Education Day 26th October 2012 Report prepared on behalf of the Scottish Head
More informationSCAN Skin Group Friday 1 st November 2013
SCAN Skin Group Friday 1 st November 2013 Dermatology Seminar Room, Lauriston Buildings with videolinks to Oncology Seminar Room, Western General Hospital and Borders General Hospital. MINUTES Present
More informationabcdefghijklmnopqrstu
CMO and Public Health Directorate Health Improvement Strategy Division Dear Colleague Scottish Abdominal Aortic Aneurysm Screening Programme This CEL outlines the plan for the implementation of the AAA
More informationAudit Report. Report of the 2010 Clinical Audit Data. West of Scotland Cancer Network. Lung Cancer Managed Clinical Network
West of Scotland Cancer Network Lung Cancer Managed Clinical Network Audit Report Report of the 2010 Clinical Audit Data Dr Richard Jones Consultant Clinical Oncologist MCN Clinical Lead Tracey Cole MCN
More informationAudit Report Report of the 2015 Clinical Audit Data
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Audit Report Report of the 2015 Clinical Audit Data Professor Stephen Wigmore Consultant
More informationAcute Leukaemia Quality Performance Indicators
Acute Leukaemia Quality Performance Indicators Patients diagnosed between July 2014 and June 2017 Publication date 19 June 2018 An Official Statistics publication for Scotland This is an Official Statistics
More informationColorectal Cancer Quality Performance Indicators
Publication Report Colorectal Cancer Quality Performance Indicators Patients diagnosed between April 2013 and March 2016 Publication date 27th June 2017 An Official Statistics Publication for Scotland
More informationIntegrated Cancer Services Action Plan. Colchester Hospital University NHS Foundation Trust 31 March 2014
Integrated Cancer Services Action Plan Colchester Hospital University NHS Foundation Trust 31 March KEY Implemented, clearly evidenced and externally approved On Track to deliver Some issues narrative
More informationMental Health Collaborative. Dementia Summary of Activity. April 2010
Mental Health Collaborative Dementia Summary of Activity April 2010 The following extracts provide either one example of a Board s dementia improvement activity or a brief summary of a Board s current
More informationThe Hepatitis C Action Plan for Scotland: Draft Guidelines for Hepatitis C Care Networks
The Hepatitis C Action Plan for Scotland: Draft Guidelines for Hepatitis C Care Networks Royal College of Physicians of Edinburgh Friday 12 October 2007 CONTENTS 1.0 ACCOUNTABILITY AND ORGANISATION 2.0
More informationSouth Lanarkshire Council. Autism Strategy. Action Plan. Update April 2014
South Lanarkshire Council Autism Strategy Action Plan Update April 2014 Ten Indicators for current best practice in the provision of effective Autism Spectrum Disorder (ASD) services 1. A local Autism
More informationThe Ayrshire Hospice
Strategy 2010-2015 Welcome... The Ayrshire Hospice : Strategy 2010-2015 Index 05 06 08 09 10 12 15 17 19 Foreword Our vision and purpose Our guiding principles Our achievements 1989-2010 Our priorities
More informationNHS GG&C Introduction of Freestyle Libre flash glucose monitoring system
NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system The Freestyle Libre flash glucose monitoring system is a sensor based, factory-calibrated system that measures interstitial fluid
More informationAudit Report. Breast Cancer Quality Performance Indicators. Patients diagnosed during Published: February 2018
Breast Cancer Managed Clinical Network Audit Report Breast Cancer Quality Performance Indicators Patients diagnosed during 2016 Published: February 2018 Mr Douglas Brown NOSCAN Breast Cancer MCN Clinical
More informationVolunteering in NHSScotland Developing and Sustaining Volunteering in NHSScotland
NG11-07 ing in NHSScotland Developing and Sustaining ing in NHSScotland Outcomes The National Group for ing in NHS Scotland agreed the outcomes below which formed the basis of the programme to develop
More informationDESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for
DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for 2008-11 1. Aims, Outcomes and Outputs The National Service Framework Designed to Tackle Renal Disease in Wales sets standards
More informationTesticular Cancer Quality Performance Indicators
Testicular Cancer Quality Performance Indicators Patients diagnosed between October 2014 and September 2017 Publication date 28 August 2018 An Official Statistics publication for Scotland This is an Official
More informationEngaging People Strategy
Engaging People Strategy 2014-2020 Author: Rosemary Hampson, Public Partnership Co-ordinator Executive Lead Officer: Richard Norris, Director, Scottish Health Council Last updated: September 2014 Status:
More informationREPORT ON PROSPECTIVE AUDIT OF LYMPHOMA PATIENTS BORDERS, FIFE, AND LOTHIAN DIAGNOSED IN 2008
SE Scotland Cancer Network SCAN AUDIT REPORT ON PROSPECTIVE AUDIT OF LYMPHOMA PATIENTS BORDERS, FIFE, AND LOTHIAN DIAGNOSED IN 2008 Reports prepared by: Christine Maguire SCAN Cancer Audit Facilitator
More informationPublished: July 2014 Updated: October 2017 (v2.0)
Scottish Cancer Taskforce National Cancer Quality Steering Group Clinical Trial and Research Study Access Quality Performance Indicators Published: July 2014 Updated: October 2017 (v2.0) Published by:
More informationStructured diabetes patient education in Scotland
Dr Joan McDowell PhD, MN, Diploma in Nursing, RN, SCM, DN, Senior Lecturer, College of Medical, Veterinary & Life Sciences, School of Medicine, Nursing & Health Care, Glasgow, UK Professor Sandra MacRury
More informationHealth & Social Care Research Strategy
Health & Social Care Research Strategy 2015-2020 http://www.gov.scot/publications/2015/10/5164 The ambition of this strategy is to increase the level of high-quality health research conducted in Scotland,
More informationWest of Scotland Cancer Network. Cancer in Scotland: Monitoring Report April 2008 March 2009
West of Scotland Cancer Network Cancer in Scotland: Monitoring Report April 2008 March 2009 Page 0 Contents Page No. 1. Introduction 2 2. Regional Cancer Advisory Group (RCAG) 2 3. Managed Clinical Networks
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MVCN EAST AND NORTH HERTFORDSHIRE Mount Vernon Cancer Centre Cancer Network MDT (11-2K-1) - 2011/12 Date Self Assessment Completed
More informationNHS Greater Glasgow & Clyde. Managed Clinical Network for Diabetes. Annual Report
NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes Annual Report 2009 / 2010 1. Introduction This annual report of the NHS Greater Glasgow and Clyde (NHS GGC) Managed Clinical Network (MCN)
More informationUnited Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2018 report
United Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2018 report 20 June 2018 UKIACR Performance Indicators 2018 report 1 Contents Introduction... 3 Commentary for
More informationHaemato-oncology Clinical Forum. 20 th June 2013
Haemato-oncology Clinical Forum 20 th June 2013 Welcome Dr Majid Kazmi, LCA Haemato-oncology Pathway Group Chair Purpose of today Provide an update on progress of the LCA to date Identify priorities for
More informationSurvey Scottish Diabetes. Survey Monitoring Group
Scottish Diabetes Survey 2009 Scottish Diabetes Survey Monitoring Group 2 Foreword The Scottish Diabetes Survey is now in its ninth year. This 2009 Survey, as with previous versions, continues to demonstrate
More informationMental Health Collaborative Dementia Summary of Activity
Mental Health Collaborative Dementia Summary of Activity October 2010 The following extracts provide either one example of a Board s dementia improvement activity or a brief summary of a Board s current
More informationROLE SPECIFICATION FOR MACMILLAN GPs
ROLE SPECIFICATION FOR MACMILLAN GPs November 2010 History of Macmillan GPs Macmillan Cancer Support has funded GP positions from the early 1990 s, following the success of our investment in supporting
More informationBritish Association of Stroke Physicians Strategy 2017 to 2020
British Association of Stroke Physicians Strategy 2017 to 2020 1 P age Contents Introduction 3 1. Developing and influencing local and national policy for stroke 5 2. Providing expert advice on all aspects
More informationAudit Report. Brain and CNS Cancer Quality Performance Indicators. Report of the 2014 Clinical Audit Data
North, South East and West of Scotland Cancer Networks Neuro-Oncology Cancers Audit Report Brain and CNS Cancer Quality Performance Indicators Report of the 2014 Clinical Audit Data Dr Avinash Kanodia
More informationItem No: 6. Meeting Date: Tuesday 12 th December Glasgow City Integration Joint Board Performance Scrutiny Committee
Item No: 6 Meeting Date: Tuesday 12 th December 2017 Glasgow City Integration Joint Board Performance Scrutiny Committee Report By: Susanne Millar, Chief Officer, Strategy & Operations / Chief Social Work
More informationAHP Musculoskeletal Service Redesign. Judith Reid MSc MMACP Consultant Physiotherapist in MSK NHS Ayrshire and Arran
AHP Musculoskeletal Service Redesign Judith Reid MSc MMACP Consultant Physiotherapist in MSK NHS Ayrshire and Arran Local Drivers Routine referral practice Via acute care, duplication Long waiting times
More informationHead and Neck QPI Group Audit Report Head and Neck Quality Performance Indicators Consultant Clinical Oncologist, NHS Grampian
Head and Neck QPI Group Audit Report Head and Neck Quality Performance Indicators Patients diagnosed April 2016 March 2017 Published: February 2018 Dr Rafael Moleron Consultant Clinical Oncologist, NHS
More informationHEALTH AND SPORT COMMITTEE AGENDA. 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018
HS/S5/18/14/A HEALTH AND SPORT COMMITTEE AGENDA 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018 The Committee will meet at 10.00 am in the James Clerk Maxwell Room (CR4). 1. Scottish Health Council Review:
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician GMCN ROYAL WOLVERHAMPTON HOSPITALS The Royal Wolverhampton Hospitals Trust Lung MDT (11-2C-1) - 2011/12 Dr Angela Morgan
More informationNational Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
More informationWHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE
WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE EXECUTIVE SUMMARY Incidence of cancer is rising, with one in two people born after 1960 expected to be diagnosed
More informationSelective Dorsal Rhizotomy (SDR) Scotland Service Pathway
Selective Dorsal Rhizotomy (SDR) Scotland Service Pathway This pathway should to be read in conjunction with the attached notes. The number in each text box refers to the note that relates to the specific
More informationBritish Dietetic Association-Dietetics Today. Glasgow & Clyde Weight Management Service
British Dietetic Association-Dietetics Today Glasgow & Clyde Weight Management Service Dr Marie L Prince Chartered Clinical Psychologist Contact: marie.prince@ggc.scot.nhs.uk GCWMS Ward 23 Surgical Block
More informationTHE SCOTTISH ENHANCED SERVICES PROGRAMME FOR PRIMARY AND COMMUNITY CARE ( ) Falls Prevention and Bone Health Service Specification
THE SCOTTISH ENHANCED SERVICES PROGRAMME FOR PRIMARY AND COMMUNITY CARE (2007-2009) Falls Prevention and Bone Health Service Specification Rationale The Delivery Framework for Adult Rehabilitation and
More informationPalliative & End of Life Care Plan
Palliative & End of Life Care Plan 2018-2023 Contents 1. Palliative Care Definition Page 1 2. Our Vision Page 2 3. Key Aims Page 2 4. Planned Actions Page 3-5 5. Priorities Page 6-7 6. Appendix 1 HSCP
More informationLung Cancer Quality Performance Indicators
Publication Report Lung Cancer Quality Performance Indicators Patients diagnosed during April 2013 to December 2015 Publication date 28 th February 2017 RESTRICTED STATISTICS Release embargoed until Tuesday
More informationSouth Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member
Agenda item: 9.4 Subject: Presented by: Submitted to: South Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member Governing Body Date: 28 th July Purpose of paper:
More informationCancer Waiting Times in NHSScotland
Publication Report Cancer Waiting Times in NHSScotland 1 July to 30 September 2017 Publication date 12 December 2017 A National Statistics Publication for Scotland Contents Introduction... 3 Main points...
More informationPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation Consensus Statement ~ October 2011 Contents 1 About 3 2 Introduction 5 3 Development of the consensus
More informationScottish Pathology Network (SPAN) Progress Report Oct 2008
Scottish Pathology Network (SPAN) Progress Report Oct 2008 SPAN SPAN Pathology configuration in Scotland Operation of the network Context (diagnostics in Scotland) Common challenges Concerted responses
More informationA minute of the PASS Monitoring and Evaluation Advisory Group. held on Friday 30 th October in Meeting Room 4, Delta House
Patient Advice and Support Service (PASS): Monitoring and Evaluation Advisory Group A minute of the PASS Monitoring and Evaluation Advisory Group held on Friday 30 th October 2015 in Meeting Room 4, Delta
More informationCancer Waiting Times in NHSScotland
Cancer Waiting Times in NHSScotland 1 October to 31 December 2017 Publication date 27 March 2018 A National Statistics publication for Scotland This is a National Statistics Publication National Statistics
More informationQUEENSLAND PHYSIOTHERAPY CENTRAL ALLOCATION PROCESS PROCEDURE MANUAL
2013 QUEENSLAND PHYSIOTHERAPY CENTRAL ALLOCATION PROCESS PROCEDURE MANUAL A strategy of the: Queensland Physiotherapy Placement Collaborative 1 Version 3.1 1. BACKGROUND It is well recognised and accepted
More informationDUMFRIES AND GALLOWAY ALCOHOL AND DRUG PARTNERSHIP; PRIORITY ACTIONS AND
DUMFRIES AND GALLOWAY ALCOHOL AND DRUG PARTNERSHIP; PRIORITY ACTIONS 2013-14 AND 2014-15 RECOMMENDATION/WORKPLAN CURRENT POSITION IN D & G PLAN 1. Annual Report 1.1 Develop robust reporting mechanisms
More informationBETTER CANCER CARE AND THE FUTURE PROVISION OF CANCER CARE IN NHS LANARKSHIRE
NHS Lanarkshire Board Meeting Wednesday 23rd November Boardroom, Kirklands Corporate HQ NHS Lanarkshire Headquarters, Kirklands Fallside Road, Bothwell G71 8BB www.nhslanarkshire.co.uk BETTER CANCER CARE
More informationAcute Oncology & Chemotherapy Clinical Network Group (CNG)
Acute Oncology & Chemotherapy Clinical Network Group (CNG) Work Programme 2014-2015 Version 1.0 This Work Programme has been agreed by: Title Name Date Agreed AO & Chemotherapy CNG Chair Ernie Marshall
More informationEnhanced CPD Programme Module 1. Introducing Starting Well
Enhanced CPD Programme Module 1 Introducing Starting Well Contents Where did the need of the scheme come from? In summary, what is the scheme about? How will the scheme work? Preventive Practices Advanced
More informationSafeguarding Annual Report
Safeguarding Annual Report 2016-17 Antony Heselton Head of Safeguarding and Prevent Lead 2016-2017 June 2017 1 Contents 1. Executive Summary. 3&4 2. Standards. 4&5 3. Action Plan Review. 5 4. Activity.
More informationThe next steps
Greater Manchester Hepatitis C Strategy The next steps 2010-2013 Endorsed by GM Director of Public Health group January 2011 Hepatitis Greater Manchester Hepatitis C Strategy 1. Introduction The Greater
More informationNational Cancer Peer Review Programme
National Cancer Peer Review Programme Julia Hill Acting Deputy National Co-ordinator What is Cancer Peer Review? A quality assurance process for cancer services. An integral part of Improving Outcomes
More informationImplementation of High Risk Human Papilloma Virus (Hr-HPV) Primary Testing
Implementation of High Risk Human Papilloma Virus (Hr-HPV) Primary Testing Background In Nov 2015 following a review of evidence the UK National Screening Committee made a recommendation to the UK countries
More information